Back to calendar
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
REGN reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026
Q2 2026
Est. EPS: $10.16
Actual EPS: $9.47
Company overview
Market Cap$72.9B
SectorHealth Technology
IndustryPharmaceuticals: Major